C4 Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 Gennaio 2024 - 1:00PM
C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage
biopharmaceutical company dedicated to advancing targeted protein
degradation science to develop a new generation of small-molecule
medicines and transform how disease is treated, today announced
that the Company will present at the upcoming 42nd Annual J.P.
Morgan Healthcare Conference taking place in San Francisco on
Thursday, January 11 at 9:00 am PST (12:00 pm EST).
A live webcast of the presentation can be accessed on the
“Events & Presentations” page of the Investors section on the
Company’s website at www.c4therapeutics.com. A replay of the
webcast will be archived on the C4T website for at least two weeks
following the presentation.
About C4 TherapeuticsC4 Therapeutics (C4T)
(Nasdaq: CCCC) is a clinical-stage biopharmaceutical company
dedicated to delivering on the promise of targeted protein
degradation science to create a new generation of medicines that
transforms patients’ lives. C4T is leveraging its TORPEDO® platform
to efficiently design and optimize small-molecule medicines that
harness the body’s natural protein recycling system to rapidly
degrade disease-causing proteins, offering the potential to
overcome drug resistance, drug undruggable targets and improve
patient outcomes. C4T is advancing multiple targeted oncology
programs to the clinic and expanding its research platform to
deliver the next wave of medicines for difficult-to-treat diseases.
For more information, please visit www.c4therapeutics.com.
Contacts:
Investors: Courtney SolbergSenior Manager, Investor
RelationsCSolberg@c4therapeutics.com
Media: Loraine Spreen Senior Director, Corporate Communications
& Patient Advocacy LSpreen@c4therapeutics.com
Grafico Azioni C4 Therapeutics (NASDAQ:CCCC)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni C4 Therapeutics (NASDAQ:CCCC)
Storico
Da Mag 2023 a Mag 2024